Related Experiment Video
Updated: Jan 9, 2026
06:17
Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
24.8K
An in vivo assay for osteoclast activity using mouse calvaria
Christopher Grieg1,2, Maya Deza Culbertson1, J Patrick O'Connor1,2
1Department of Orthopaedics, Rutgers-New Jersey Medical School, Newark, New Jersey, USA.
Animal Models and Experimental Medicine
|December 2, 2025
Summary
A new in vivo method uses micro-computed tomography to measure osteoclast activity and bone loss in mouse calvaria. This technique helps assess potential osteoporosis therapies targeting osteoclasts.
Area of Science:
- Bone Biology
- Skeletal Physiology
- Pharmacology
Background:
- Osteoclasts are crucial for bone remodeling and health.
- Dysfunctional osteoclasts contribute to osteoporosis and fracture risk.
- Limited in vivo methods exist to directly assess osteoclast activity.
Purpose of the Study:
- To develop and validate a novel in vivo method for measuring osteoclast-mediated bone loss.
- To assess the utility of this method in evaluating osteoporosis therapies.
Main Methods:
- A novel in vivo technique was developed to measure osteoclast resorption pits in mouse calvaria.
- Micro-computed tomography was employed for pit measurement.
- The method was validated using zoledronic acid, an osteoporosis drug.
Main Results:
- The developed method successfully measured osteoclast-mediated bone loss in mouse calvaria.
- Zoledronic acid treatment demonstrated expected effects on osteoclast activity, validating the model.
- The mouse calvaria model is suitable for assessing therapies targeting osteoclasts.
Conclusions:
- A novel, effective in vivo method for measuring osteoclast activity and bone loss has been established.
- This micro-computed tomography-based approach in mouse calvaria provides a valuable tool for preclinical assessment of osteoporosis treatments.
- The validated model aids in the development of new therapies to combat bone loss and fracture risk.
